These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 26705203)
1. Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study. Kuo CC; Yeh HC; Chen B; Tsai CW; Lin YS; Huang CC Medicine (Baltimore); 2015 Dec; 94(51):e2175. PubMed ID: 26705203 [TBL] [Abstract][Full Text] [Related]
2. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891 [TBL] [Abstract][Full Text] [Related]
3. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD. Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959 [TBL] [Abstract][Full Text] [Related]
4. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study. Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303 [TBL] [Abstract][Full Text] [Related]
5. Influence of Medications Containing Acid Salts on Serum Bicarbonate in CKD. Gardner J; Tuttle K; Raphael KL Kidney360; 2020 May; 1(5):330-336. PubMed ID: 35369374 [TBL] [Abstract][Full Text] [Related]
6. Dietary Acid Load is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease. Ikizler HO; Zelnick L; Ruzinski J; Curtin L; Utzschneider KM; Kestenbaum B; Himmelfarb J; de Boer IH J Ren Nutr; 2016 Mar; 26(2):93-102. PubMed ID: 26508542 [TBL] [Abstract][Full Text] [Related]
7. Low Serum Bicarbonate and CKD Progression in Children. Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307 [TBL] [Abstract][Full Text] [Related]
9. Metabolic Acidosis of CKD: An Update. Kraut JA; Madias NE Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665 [TBL] [Abstract][Full Text] [Related]
10. Associations of Metabolic Syndrome and Abdominal Obesity with Anion Gap Metabolic Acidosis among US Adults. Lambert DC; Kane J; Slaton A; Abramowitz MK Kidney360; 2022 Nov; 3(11):1842-1851. PubMed ID: 36514392 [TBL] [Abstract][Full Text] [Related]
11. Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study. Goldenstein L; Driver TH; Fried LF; Rifkin DE; Patel KV; Yenchek RH; Harris TB; Kritchevsky SB; Newman AB; Sarnak MJ; Shlipak MG; Ix JH; Am J Kidney Dis; 2014 Oct; 64(4):542-9. PubMed ID: 24953890 [TBL] [Abstract][Full Text] [Related]
12. Serum anion gap and blood pressure in the national health and nutrition examination survey. Taylor EN; Forman JP; Farwell WR Hypertension; 2007 Aug; 50(2):320-4. PubMed ID: 17562979 [TBL] [Abstract][Full Text] [Related]
13. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study. Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868 [TBL] [Abstract][Full Text] [Related]
14. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. Kanda E; Ai M; Yoshida M; Kuriyama R; Shiigai T BMC Nephrol; 2013 Jan; 14():4. PubMed ID: 23298330 [TBL] [Abstract][Full Text] [Related]
15. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease. Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183 [TBL] [Abstract][Full Text] [Related]
16. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial. Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease. Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932 [TBL] [Abstract][Full Text] [Related]
18. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter? Bushinsky DA Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease. Raphael KL; Zhang Y; Ying J; Greene T Nephrology (Carlton); 2014 Oct; 19(10):648-54. PubMed ID: 25066359 [TBL] [Abstract][Full Text] [Related]
20. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe? Căpuşă C; Ştefan G; Stancu S; Lipan M; Tsur LD; Mircescu G Medicine (Baltimore); 2017 Nov; 96(47):e8802. PubMed ID: 29381982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]